Notice2023-02619
Center for Scientific Review; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 8, 2023
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 26 (Wednesday, February 8, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 26 (Wednesday, February 8, 2023)]
[Notices]
[Page 8298]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-02619]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Circadian and Interoceptive functions.
Date: March 3, 2023.
Time: 11:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Bishop, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408-
9664, <a href="/cdn-cgi/l/email-protection#5d3f342e35322d371d3e2e2f73333435733a322b"><span class="__cf_email__" data-cfemail="24464d574c4b544e644757560a4a4d4c0a434b52">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Clinical Care and Health Interventions.
Date: March 6-7, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Martha M. Faraday, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3110, MSC 7808, Bethesda, MD
20892, (301) 435-3575, <a href="/cdn-cgi/l/email-protection#422423302326233b2f022131306c2c2b2a6c252d34"><span class="__cf_email__" data-cfemail="d1b7b0a3b0b5b0a8bc91b2a2a3ffbfb8b9ffb6bea7">[email protected]</span></a>.
Name of Committee: Biology of Development and Aging Integrated
Review Group; Drug Discovery and Molecular Pharmacology C Study
Section.
Date: March 6-7, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jeffrey Smiley, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD
20892, (301) 272-4596, <a href="/cdn-cgi/l/email-protection#ddaeb0b4b1b8a4b7bc9dbeaeaff3b3b4b5f3bab2ab"><span class="__cf_email__" data-cfemail="50233d393c35293a31103323227e3e39387e373f26">[email protected]</span></a>.
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Lifestyle and Health Behaviors Study
Section.
Date: March 6-7, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa T. Wigfall, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007G, Bethesda, MD 20892, (301)
594-5622, <a href="/cdn-cgi/l/email-protection#1e697779787f7272726a5e737f77723070777630797168"><span class="__cf_email__" data-cfemail="aaddc3cdcccbc6c6c6deeac7cbc3c684c4c3c284cdc5dc">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Fogarty Global Brain Disorders.
Date: March 7-8, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Todd Everett White, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-3962,
<a href="/cdn-cgi/l/email-protection#285c474c4c065f40415c4d68464140064f475e"><span class="__cf_email__" data-cfemail="2a5e454e4e045d42435e4f6a444342044d455c">[email protected]</span></a>.
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Cardiovascular and Respiratory Diseases
Study Section.
Date: March 7-8, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mohammed F. A. Elfaramawi, Ph.D., MD, Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007F, Bethesda, MD 20892, (301)
480-1142, <a href="/cdn-cgi/l/email-protection#12777e747360737f73657b7f74527161603c7c7b7a3c757d64"><span class="__cf_email__" data-cfemail="4c29202a2d3e2d212d3b25212a0c2f3f3e62222524622b233a">[email protected]</span></a>.
Name of Committee: Applied Immunology and Disease Control
Integrated Review Group; Drug Discovery and Molecular Pharmacology A
Study Section.
Date: March 7-8, 2023.
Time: 9:30 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Bidyottam Mittra, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-0000,
<a href="/cdn-cgi/l/email-protection#d1b3b8b5a8bea5a5b0bcffbcb8a5a5a3b091bfb8b9ffb6bea7"><span class="__cf_email__" data-cfemail="ea88838e93859e9e8b87c487839e9e988baa848382c48d859c">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Cancer Immunology and Immunotherapy I.
Date: March 7, 2023.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192, MSC 7806, Bethesda, MD
20892, 301-451-4467, <a href="/cdn-cgi/l/email-protection#ff9790889e8d9b85bf929e9693d1919697d1989089"><span class="__cf_email__" data-cfemail="bed6d1c9dfccdac4fed3dfd7d290d0d7d690d9d1c8">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 2, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-02619 Filed 2-7-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 8, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.